The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
2-((S)-2-amino-3-(4-hydroxyphenyl)propanoyl)-1,2,3,4-tetrahydroisoquinoline-3-carboxylic acid ID: ALA4166622
PubChem CID: 10664865
Max Phase: Preclinical
Molecular Formula: C19H20N2O4
Molecular Weight: 340.38
Molecule Type: Small molecule
This compound is available for customization.
Associated Items:
Names and Identifiers Canonical SMILES: N[C@@H](Cc1ccc(O)cc1)C(=O)N1Cc2ccccc2CC1C(=O)O
Standard InChI: InChI=1S/C19H20N2O4/c20-16(9-12-5-7-15(22)8-6-12)18(23)21-11-14-4-2-1-3-13(14)10-17(21)19(24)25/h1-8,16-17,22H,9-11,20H2,(H,24,25)/t16-,17?/m0/s1
Standard InChI Key: VUOZTGVYOFFWCN-BHWOMJMDSA-N
Molfile:
RDKit 2D
25 27 0 0 0 0 0 0 0 0999 V2000
25.2340 -21.6534 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
25.2329 -22.4807 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
25.9482 -22.8916 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
26.6652 -22.4803 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
26.6623 -21.6498 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
25.9464 -21.2386 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
24.5174 -22.8907 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
27.3717 -21.2325 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
28.0882 -21.6444 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
28.8017 -21.2272 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
28.0913 -22.4695 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
29.5183 -21.6391 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
28.7987 -20.4021 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
29.5191 -22.4626 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
30.9463 -21.6347 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
30.2293 -21.2184 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
30.9475 -22.4606 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
30.2334 -22.8657 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
30.2303 -23.6852 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
30.9404 -24.1008 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
31.6551 -23.6866 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
31.6548 -22.8684 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
30.2259 -20.3934 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
30.9393 -19.9799 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
29.5092 -19.9859 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
1 2 2 0
2 3 1 0
3 4 2 0
4 5 1 0
5 6 2 0
6 1 1 0
2 7 1 0
5 8 1 0
8 9 1 0
9 10 1 0
9 11 1 1
10 12 1 0
10 13 2 0
12 14 1 0
12 16 1 0
14 18 1 0
17 15 1 0
15 16 1 0
17 18 2 0
18 19 1 0
19 20 2 0
20 21 1 0
21 22 2 0
22 17 1 0
16 23 1 0
23 24 1 0
23 25 2 0
M END Associated Targets(Human) Associated Targets(non-human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 340.38Molecular Weight (Monoisotopic): 340.1423AlogP: 1.30#Rotatable Bonds: 4Polar Surface Area: 103.86Molecular Species: ACIDHBA: 4HBD: 3#RO5 Violations: ┄HBA (Lipinski): 6HBD (Lipinski): 4#RO5 Violations (Lipinski): ┄CX Acidic pKa: 3.55CX Basic pKa: 8.01CX LogP: -0.40CX LogD: -0.48Aromatic Rings: 2Heavy Atoms: 25QED Weighted: 0.78Np Likeness Score: 0.01
References 1. Olson KM, Keresztes A, Tashiro JK, Daconta LV, Hruby VJ, Streicher JM.. (2018) Synthesis and Evaluation of a Novel Bivalent Selective Antagonist for the Mu-Delta Opioid Receptor Heterodimer that Reduces Morphine Withdrawal in Mice., 61 (14): [PMID:29939746 ] [10.1021/acs.jmedchem.8b00403 ]